BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15858705)

  • 1. [Lectin-reactive alpha-fetoprotein in tyrosinaemia type I].
    Baumann U; Duhme V; Knerr I; Pronicka E; Auth MK; Voit PT
    Klin Padiatr; 2005; 217(3):142-6. PubMed ID: 15858705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin-reactive alpha-fetoprotein in patients with tyrosinemia type I and hepatocellular carcinoma.
    Baumann U; Duhme V; Auth MK; McKiernan PJ; Holme E
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):77-82. PubMed ID: 16819381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?
    Koelink CJ; van Hasselt P; van der Ploeg A; van den Heuvel-Eibrink MM; Wijburg FA; Bijleveld CM; van Spronsen FJ
    Mol Genet Metab; 2006 Dec; 89(4):310-5. PubMed ID: 17008115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin affinity electrophoresis of alpha-fetoprotein. Increased specificity and sensitivity as a marker of hepatocellular carcinoma.
    Hirai H; Taketa K
    J Chromatogr; 1992 Jun; 604(1):91-4. PubMed ID: 1379253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.
    Shiraki K; Takase K; Tameda Y; Hamada M; Kosaka Y; Nakano T
    Hepatology; 1995 Sep; 22(3):802-7. PubMed ID: 7544756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein].
    Matsuyama H; Morishita Y; Nakane K; Fukatsu T; Nakashima N
    Rinsho Byori; 1994 Oct; 42(10):1021-8. PubMed ID: 7527871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of cirrhotic regenerative liver nodules upon NTBC treatment in a child with tyrosinaemia type I.
    Crone J; Möslinger D; Bodamer OA; Schima W; Huber WD; Holme E; Stöckler Ipsiroglu S
    Acta Paediatr; 2003 May; 92(5):625-8. PubMed ID: 12839296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma].
    Tamura A; Oita T; Sakizono K; Nakajima T; Kasakura S
    Rinsho Byori; 1998 Feb; 46(2):158-62. PubMed ID: 9528340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma.
    Khien VV; Mao HV; Chinh TT; Ha PT; Bang MH; Lac BV; Hop TV; Tuan NA; Don LV; Taketa K; Satomura S
    Int J Biol Markers; 2001; 16(2):105-11. PubMed ID: 11471892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver Cancer in Tyrosinemia Type 1.
    van Ginkel WG; Pennings JP; van Spronsen FJ
    Adv Exp Med Biol; 2017; 959():101-109. PubMed ID: 28755188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.
    Kumada T; Nakano S; Takeda I; Kiriyama S; Sone Y; Hayashi K; Katoh H; Endoh T; Sassa T; Satomura S
    J Hepatol; 1999 Jan; 30(1):125-30. PubMed ID: 9927159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma.
    Yamashiki N; Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Inoue K; Okamura A; Arita S; Harada K
    Oncol Rep; 1999; 6(6):1229-32. PubMed ID: 10523686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
    Tada T; Kumada T; Toyoda H; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kitabatake S; Kuzuya T; Nonogaki K; Shimizu J; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J; Satomura S
    Liver Int; 2005 Aug; 25(4):848-53. PubMed ID: 15998436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin-affinity electrophoresis for the detection of AFP microheterogeneities in patients with hepatocellular carcinoma.
    Zaninotto M; Ujka F; Lachin M; Bernardi D; Marafi C; Farinati F; Plebani M
    Anticancer Res; 1996; 16(1):305-9. PubMed ID: 8615626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma.
    Hayashi K; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Miyata A; Shimizu H; Satomura S
    Am J Gastroenterol; 1999 Oct; 94(10):3028-33. PubMed ID: 10520864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in tyrosinemia type 1 without clear increase of AFP.
    van Ginkel WG; Gouw AS; van der Jagt EJ; de Jong KP; Verkade HJ; van Spronsen FJ
    Pediatrics; 2015 Mar; 135(3):e749-52. PubMed ID: 25667247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
    van Staden L; Bukofzer S; Kew MC; Savage N
    J Gastroenterol Hepatol; 1992; 7(3):260-5. PubMed ID: 1377039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontransplant treatment of tyrosinemia.
    Holme E; Lindstedt S
    Clin Liver Dis; 2000 Nov; 4(4):805-14. PubMed ID: 11232358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.